| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
INSERM U.531, Groupe de Recherche de Biologie et Pathologie Digestives, Institut Louis Bugnard, Bat. L3, 31403 Toulouse, France
The proliferative effects of gastrin on normal and malignant gastrointestinal tissues have been shown to be mediated by a G protein-coupled receptor (GPCR), the cholecystokinin B receptor. The c-Jun NH2-terminal kinase (JNK) pathway has been implicated in the regulation of mitogenesis by growth factors or cytokines. However, the contribution of this signaling cascade to the proliferative effects of GPCR remains largely unknown. Here, we show that cholecystokinin B receptor occupancy by gastrin leads to the activation of the JNK pathway. The mechanism involves certain protein kinase C isoforms and Src family kinases other than p60Src. The complex p130Cas/CrkII, known to be involved in JNK activation, is also activated in response to gastrin by a protein kinase C- and Src-dependent mechanism. However, gastrin-induced CrkII and JNK pathways are independent. Using a dominant negative mutant of c-Jun, we blocked the ability of gastrin to induce DNA synthesis, demonstrating a major role of the JNK pathway in the growth-promoting effect of a GPCR agonist.
This article has been cited by other articles:
![]() |
M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leung-Theung-Long, E. Roulet, P. Clerc, C. Escrieut, S. Marchal-Victorion, B. Ritz-Laser, J. Philippe, L. Pradayrol, C. Seva, D. Fourmy, et al. Essential Interaction of Egr-1 at an Islet-specific Response Element for Basal and Gastrin-dependent Glucagon Gene Transactivation in Pancreatic {alpha}-Cells J. Biol. Chem., March 4, 2005; 280(9): 7976 - 7984. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bierkamp, S. Bonhoure, A. Mathieu, P. Clerc, D. Fourmy, L. Pradayrol, C. Seva, and M. Dufresne Expression of Cholecystokinin-2/Gastrin Receptor in the Murine Pancreas Modulates Cell Adhesion and Cell Differentiation in Vivo Am. J. Pathol., December 1, 2004; 165(6): 2135 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rouet-Benzineb, C. Rouyer-Fessard, A. Jarry, V. Avondo, C. Pouzet, M. Yanagisawa, C. Laboisse, M. Laburthe, and T. Voisin Orexins Acting at Native OX1 Receptor in Colon Cancer and Neuroblastoma Cells or at Recombinant OX1 Receptor Suppress Cell Growth by Inducing Apoptosis J. Biol. Chem., October 29, 2004; 279(44): 45875 - 45886. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ling, T. Zhu, and P. E. Lobie Src-CrkII-C3G-dependent Activation of Rap1 Switches Growth Hormone-stimulated p44/42 MAP Kinase and JNK/SAPK Activities J. Biol. Chem., July 11, 2003; 278(29): 27301 - 27311. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |